One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Report Library
  • Who Trust Us
  • Datafeature
  • [email protected]
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Report Library
  • Who Trust Us
  • Datafeature
Home ➤ Life Science ➤ Pharmaceuticals ➤ Drug Repurposing Market
Drug Repurposing Market
Drug Repurposing Market
Published date: Apr 2022 • Formats:
Request Sample
  • Home ➤ Life Science ➤ Pharmaceuticals ➤ Drug Repurposing Market

Global Drug Repurposing Market By Disease Indication (Oncology, CNS Disorders, Neurodegenerative Diseases, Other), By End User (Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), Clinical Research Institutes/ Organizations & Pharma and Biotech Industry), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

  • Published date: Apr 2022
  • Report ID: 25213
  • Number of Pages: 295
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • Global Drug Repurposing Market is expected to be driven by increased government investment support and low cost of R&D associated with it

    Market.US announces publication of its most recently generated research report titled, “Global Drug Repurposing Market by Disease Indication (Oncology, CNS Disorders, Neurodegenerative Diseases, and Other Disease Indications), By End User (Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), Clinical Research Institutes/ Organizations & Pharma and Biotech Industry), and by Region – Global Forecast to 2031”, which offers a holistic view of the global drug repurposing market through systematic segmentation that covers every aspect of the target market.

    The global drug repurposing market is projected to be US$ 27,343.4 Mn in 2021 to reach US$ 39,139.7 Mn by 2031 at a CAGR of 3.8%.

    Drug Repurposing (DR) is the process of identifying new medical uses or pharmacological indications for old or existing licensed drugs. Drug repurposing is also known as drug repositioning, drug rescuing, drug recycling, drug re-tasking, drug reprofiling, drug redirection, and therapeutic switching. It involves establishing new therapeutic uses for known drugs, including approved, discontinued, obsolete and experimental drugs.

    Repurposed drugs are considered cost-effective and time-efficient alternatives when compared to new drugs that are under development. Some of the most successful and well-known drugs that have emerged through the DR method are sildenafil, minoxidil, aspirin, valproic acid, and methotrexate among others.

    trending_up Total Revenue in 2018

    $ 27,343.4 Mn

    trending_up Market CAGR of the Next Ten Years

    3.8%

    no_encryption Market Value (US$ Mn), Share (%) and Growth Rate (%) Comparison 2012-2028
    Purchase this report or a membership to unlock the market value (US$ Mn), share (%) and growth rate (%) comparison for this industry.
    • By Type
    • By Region
    • By Application
    no_encryption Leading Companies Financial Highlights
    Purchase this report or a membership to unlock the leading companies financial highlights for this industry.

    trending_up Market Revenue of the Next Ten Years

    $ 39,139.7 Mn

    In the context of oncology, DR refers to the reuse of non-cancer drugs to treat malignant tumors, rather than opt for new drugs to solve symptoms associated with existing cancer treatments. For cancer indications, the main goal of re-purposing treatment is greater efficacy owing to the need to promptly treat cancer patients.

    Drug reuse processes can be seen as a response to the decline in oncology drug development productivity/activity, as a strategy to shorten overall development time, and as a source of low-cost treatments to meet the surge in the unmet needs of cancer patients.

    Global Drug Repurposing Market Revenue (US$ Mn), 2021–2031

    Global Drug Repurposing Market Revenue 2021

    Cancer is a major health disorder, whose prominence is expected to increase in the coming years and is a leading cause of death worldwide. The limitations of immunotherapy and the emergence of drug resistance are elements that have compromised the prognosis of cancer patients, resulting in the search for effective, alternative treatments.

    In addition, traditionally, it takes approximately 12 to 15 years to discover a new drug, and this process requires a huge budget. Drug reuse for the purposes of cancer treatment is considered an alternative treatment strategy for oncological disorders.

    Moreover, it facilitates the rapid identification of drugs with relatively lesser costs and poses lower risks for patients. These are some essential factors that are expected to prove to be beneficial for drug development processes, resulting in increased revenue growth prospects for this global market.

    Another factor being the complementary policies and incentive-based schemes by respective governments and philanthropic organizations of both developed and developing nations for the purposes of drug development and repurposing, coupled with increasing investments by these governments to improve and strengthen their respective healthcare and medical sectors, are expected to further propel the financial trajectory of this target industry.

    Unfortunately, stringent regulations by several governing bodies in the US, Europe, and other regions/countries pertaining to approvals for several repurposing candidates as cancer therapeutics or for alternate diseases is a major factor that could potentially hamper the financial growth of this global market over the forecast period.

    However, the surge in technological advancements such as Deep Learning, Machine Learning (ML), and Artificial Intelligence (AI) for the systematic identification of drug repurposing for polypharmacology, as well as an increase in investments for R&D activities by several governments and prominent industry players towards the development of new medications for cancer treatment are trends being presently observed. These factors are expected to further amplify profit margins for this global market.

    Global Drug Repurposing Market Attractiveness Analysis by Disease Indication, 2015–2031

    Global Drug Repurposing Market Attractiveness 2021

    Segmentation of the global drug repurposing market is achieved accordingly – Disease Indication, End-User, and Regions/Countries. On the basis of disease indication, this market is further categorized into oncology, CNS disorders, neurodegenerative diseases, and other disease indications. The oncology segment is expected to account for the majority revenue share, followed by the CNS disorders segment.

    In terms of end-user, this market is segmented into – Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), clinical research institutes/ organizations, as well as the pharma and biotech industry. The CROs sub-segment is expected to generate a majority revenue share, followed by the pharma and biotech industry sub-segment.

    The global drug repurposing market is segmented region-wise into – North America, Europe, Asia-Pacific, South America, and the MEA respectively. Among these aforementioned regions, markets in the North America region are expected to index the majority revenue share in this target sector.

    The research report on the global drug repurposing market includes profiles of some of the major companies such as Relay Therapeutics, Exscientia, SOM BIOTECH, Gero.AI, Benevolent AI, Biovista, Recursion Pharmaceuticals Inc., Algernon Pharmaceuticals, Elix Inc., Atomwise Inc., Healx, Genome Biologics, and others.

    Global Drug Repurposing Market Segmentation Based on Disease Indication, End-User and Region

    Based on Disease Indication

    • Oncology
    • CNS Disorders
    • Neurodegenerative Diseases
    • Other Disease Indications

    Based on End-User

    • Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
    • Clinical Research Institutes/ Organizations
    • Pharma and Biotech Industry

    Based on Key Players

    • Relay Therapeutics
    • Exscientia
    • SOM BIOTECH
    • Gero.AI
    • Benevolent AI
    • Biovista
    • Recursion Pharmaceuticals Inc.
    • Algernon Pharmaceuticals
    • Elix Inc.
    • Atomwise Inc.
    • Healx
    • Genome Biologics
    • others

    Based on Regions

    • North America
    • Europe
    • Asia Pacific
    • South America
    • Middle East & Africa

    For the Global Drug Repurposing Market research study, the following years have been considered to estimate the market size:

    AttributeReport Details

    Historical Years

    2016-2020

    Base Year

    2021

    Estimated Year

    2022

    Short Term Projection Year

    2028

    Projected Year

    2023

    Long Term Projection Year

    2032

    Report Coverage

    Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.

    Regional Scope

    North America, Europe, Asia-Pacific, South America, Middle East & Africa

    Country Scope

    United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa

    Share
    Tweet
    Share
    Pin
    0 Shares
    Drug Repurposing Market
    Drug Repurposing Market
    Published date: Apr 2022
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Relay Therapeutics
    • Exscientia
    • SOM BIOTECH
    • Gero.AI
    • Benevolent AI
    • Biovista
    • Recursion Pharmaceuticals Inc.
    • Algernon Pharmaceuticals
    • Elix Inc.
    • Atomwise Inc.
    • Healx
    • Genome Biologics
    • others
  • settingsSettings

Related Reports

  • Wire Braided Hydraulic Hose Market
  • Pharmacovigilance Market
  • Automotive Digital Key Market
  • Butyl Ethyl Propanediol (BEPD) Market
  • Household Ceramic Decal Market
  • Camp Cookware Market

Our Clients

  • Our Clients
Inquiry Before Buying

Drug Repurposing Market
  • 25213
  • Apr 2022
    • ★★★★★
      ★★★★★
    • (25)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
Multi User
$7,999
$3,499
USD / per unit
save 55%
Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library
Secured Payment Options
Secured Payment Options

© 2023 Market.Us. All Rights Reserved.